NEI Research News

This National Diabetes Month, there is some good news for people with eye complications from diabetes.

A clinical trial funded by the National Institutes of Health has found that the drug ranibizumab (Lucentis) is highly effective in treating proliferative diabetic retinopathy.

A chemical that could potentially be used in eye drops to reverse cataracts, the leading cause of blindness, has been identified by a team of scientists.

Because sound travels much more slowly than light, we can often see distant events before we hear them. That is why we can count the seconds between a lightning flash and its thunder to estimate their distance.

Gene therapy preserved vision in a study involving dogs with naturally occurring, late-stage retinitis pigmentosa, according to research funded by the National Eye Institute (NEI), part of the National Institutes of Health.

Researchers have used fruit flies and mice to make novel discoveries about sensory physiology at both cellular and molecular levels that are important for light processing.

The National Eye Institute (NEI), part of NIH, has appointed three new members to the National Advisory Eye Council (NAEC) who are attending their first NAEC meeting as council members today.

Researchers funded by the National Institutes of Health have developed a novel mouse model for the vision disorder Leber hereditary optic neuropathy (LHON), and found that they can use gene therapy to improve visual function in the mice.

Researchers at Johns Hopkins and the University of Washington report new research that sheds light on how the retina sets its own biological rhythm using a novel light-sensitive pigment, called neuropsin, found in nerve cells at the back of the eye.

People with a genetic predisposition for age-related macular degeneration (AMD) significantly increased their odds of developing the blinding eye disorder if they had a history of smoking and did not exercise or eat enough fruits and vegetables.